ABLYNX (D)
Identification
Symbol
ABLX
ISIN code
BE 0003877942
Exchange / Market
Euronext
Trading location
Brussels
Products family
Stocks
Market organization
EuronextBrussels
ICB
Biotechnology
Activity description
Ablynx specializes in the research and development of nanobodies (therapeutic proteins made from natural antibody fragments) intended to improve treatments for inflammatory diseases, thrombosis, cancer, and Alzheimer's disease. Net sales break down by type of income as follows:
- revenues from partnership agreements (94.6%);
- subsidies (5.4%).
Website address
www.ablynx.com
Issuer website
www.ablynx.com
Operation
IPO date
Tue 09/03/2010
IPO type
New Issue Special Session
Catégorie
New Issue Special Session
Operation procedure
OFFER SHARES